These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Alzheimer's disease: new prospects in therapy and applied experimental models]. Kubis AM; Janusz M Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of Alzheimer's disease. Gooch MD; Stennett DJ Am J Health Syst Pharm; 1996 Jul; 53(13):1545-57; quiz 1603-4. PubMed ID: 8809275 [TBL] [Abstract][Full Text] [Related]
6. Etiology and pathogenesis of Alzheimer's disease. Farlow MR Am J Health Syst Pharm; 1998 Nov; 55 Suppl 2():S5-10. PubMed ID: 9809105 [TBL] [Abstract][Full Text] [Related]
7. The neurobiology of Alzheimer's disease. Brion JP Acta Clin Belg; 1996; 51(2):80-90. PubMed ID: 8693872 [TBL] [Abstract][Full Text] [Related]
8. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps]. Kuzuhara S Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and amyloid: culprit or coincidence? Skaper SD Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834 [TBL] [Abstract][Full Text] [Related]
10. [Brain lesions, pathogenic and etiologic hypotheses of Alzheimer's disease]. Dessi F; Colle MA; Hauw JJ; Duyckaerts C Rev Prat; 1998 Nov; 48(17):1873-8. PubMed ID: 9854388 [TBL] [Abstract][Full Text] [Related]
11. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression. Cacabelos R Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277 [TBL] [Abstract][Full Text] [Related]
12. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
13. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353 [TBL] [Abstract][Full Text] [Related]
16. [The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease]. Kowalska A Neurol Neurochir Pol; 2004; 38(5):405-11. PubMed ID: 15565529 [TBL] [Abstract][Full Text] [Related]
17. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
18. [Neurobiology and molecular biology of Alzheimer's disease]. DeKosky ST Rev Neurol; 2002 Oct 16-31; 35(8):752-60. PubMed ID: 12402229 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease: a re-examination of the amyloid hypothesis. Neve RL; Robakis NK Trends Neurosci; 1998 Jan; 21(1):15-9. PubMed ID: 9464679 [TBL] [Abstract][Full Text] [Related]